<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> is a leading cause of <z:hpo ids='HP_0011420'>death</z:hpo> and the primary medical cause of acquired adult disability worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>The progressive brain injury after <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> is partly mediated by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-elicited <z:mp ids='MP_0001845'>inflammatory responses</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The vasoactive hormone adrenomedullin (AM), upregulated under various inflammatory conditions, counterbalances <z:mp ids='MP_0001845'>inflammatory responses</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>However, regulation of AM activity in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> remains largely unknown </plain></SENT>
<SENT sid="4" pm="."><plain>Recent studies have demonstrated the presence of a specific AM binding protein (that is, AMBP-1) in mammalian blood </plain></SENT>
<SENT sid="5" pm="."><plain>AMBP-1 potentiates AM biological activities </plain></SENT>
<SENT sid="6" pm="."><plain>Using a rat model of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> induced by permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), we found that plasma levels of AM increased significantly, whereas plasma levels of AMBP-1 decreased significantly after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>When given peripherally early after MCAO, exogenous human AM in combination with human AMBP-1 reduced brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume 24 and 72 h after MCAO, an effect not observed after the treatment by human AM or human AMBP-1 alone </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, treatment of human AM/AMBP-1 reduced neuron <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and morphological damage, inhibited neutrophil infiltration in the brain and decreased serum levels of S100B and <z:chebi fb="4" ids="24996">lactate</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, human AM/AMBP-1 has the ability to reduce <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced brain injury in rats </plain></SENT>
<SENT sid="10" pm="."><plain>AM/AMBP-1 can be developed as a novel therapeutic agent for patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>